Early low-dose erythropoiesis-stimulating agent therapy and progression of moderate chronic kidney disease: a randomized, placebo-controlled trial-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Early low-dose erythropoiesis-stimulating agent therapy and progression of moderate chronic kidney disease: a randomized, placebo-controlled trial

Published:2017-02-01 Issue:2 Volume:32 Page:279-287
ISSN:0931-0509
Container-title:Nephrology Dialysis Transplantation
language:en
Short-container-title:

Author:

Fliser Danilo¹,Dellanna Frank²,Koch Michael³,Wiggenhauser Alfons⁴, ,

Affiliation:

1. Department of Internal Medicine IV, Saarland University Medical Centre, Kirrbergerstrasse, Homburg/Saar, Germany

2. MVZ Davita Rhein-Ruhr, Düsseldorf, Germany

3. Centre of Nephrology, Mettmann, Germany

4. Roche Pharma AG Germany, Grenzach-Wyhlen, Germany

Publisher

Oxford University Press (OUP)

Subject

Transplantation,Nephrology

Link

http://academic.oup.com/ndt/article-pdf/32/2/279/10325749/gfw418.pdf

Reference48 articles.

1. Health-related quality of life and hemoglobin levels in chronic kidney disease patients;Finkelstein;Clin J Am Soc Nephrol,2009

2. Anemia and cardiovascular risk in the patient with kidney disease;Fishbane;Heart Fail Clin,2008

3. Association of anemia with outcomes in men with moderate and severe chronic kidney disease;Kovesdy;Kidney Int,2006

4. The effect of losartan on hemoglobin concentration and renal outcome in diabetic nephropathy of type 2 diabetes;Mohanram;Kidney Int,2008

5. Role of anemia in progression of chronic kidney disease;Rossert;Semin Nephrol,2006

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Evaluation of the nephroprotective strategy effectiveness in the late stages of chronic kidney disease;HERALD of North-Western State Medical University named after I.I. Mechnikov;2023-05-05

2. Erythropoiesis-stimulating agents for anaemia in adults with chronic kidney disease: a network meta-analysis;Cochrane Database of Systematic Reviews;2023-02-13

3. Evolving Strategies in the Treatment of Anaemia in Chronic Kidney Disease: The HIF-Prolyl Hydroxylase Inhibitors;Drugs;2022-11

4. CKD Progression;Nephrology Self-Assessment Program;2019-09

5. The interaction between post-transplant anemia and allograft function in kidney transplantation: The Japan Academic Consortium of Kidney Transplantation-II study;Clinical and Experimental Nephrology;2019-04-24

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3